Korro Bio Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Korro Bio, Inc. (KRRO) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Operating Activities
Net Income-83.58-81.17-58.03-21.96-26.51-18.75
Depreciation & Amortization3.573.632.371.601.150.81
Stock Based Compensation4.462.381.140.810.000.00
Change in Working Capital13.594.281.570.90-30.2448.65
Change in Accounts Receivable-1.700.000.000.000.000.00
Change in Accounts Payable-1.343.101.760.060.000.00
Change in Other Working Capital3.311.18-2.391.530.000.00
Other Operating Activities3.313.610.34-13.4710.423.50
Net Cash from Operating Activities-60.07-67.28-53.65-32.09-45.1934.22
Investing Activities
Capital Expenditures-17.90-7.845.14-4.456.671.06
Purchases of Investments-146.3519.0016.27-35.070.000.00
Sales/Maturities of Investments40.9019.0016.20-63.2117.07-17.20
Other Investing Activities0.000.00-0.080.000.00-282.62
Net Cash from Investing Activities-123.3511.1611.06-39.5010.40-18.26
Financing Activities
Debt Repayment0.000.00-0.830.000.000.00
Common Stock Issued67.39154.550.260.0341.6980.06
Other Financing Activities1.97-12.25-0.04-0.030.000.00
Net Cash from Financing Activities69.36187.760.02115.9556.69203.97
Summary
Effect of Forex Changes on Cash0.000.000.000.000.000.00
Net Change in Cash-114.07131.64-42.5744.3521.90219.92
Cash at Beginning of Period173.1241.4884.04222.16200.2642.29
Cash at End of Period59.0586.1841.4881.33222.16262.21
Free Cash Flow-77.98-75.12-58.78-36.54-51.8633.15
Supplemental Disclosures
Interest Paid0.000.000.910.700.000.00
Income Taxes Paid0.140.030.010.000.000.09